Gastroenterology and Hepatology Board Review 2023 (Course)
50 $
Format : 42 MP4 + 2 PDFs
File Size : 12.29 GB
This is an online video CME program on gastroenterology and hepatology with 40+ lectures covering normal function, signs, symptoms, and diseases of the gastrointestinal organs. The program is intended for gastroenterologists, hepatologists, internists, fellows in gastroenterology, and internal medicine residents interested in gastroenterology and hepatology. The lectures are delivered by recognized experts with extensive clinical experience and cover topics like GERD, motility disorders, inflammatory bowel disease, viral hepatitis, autoimmune liver disorders, pancreatitis, gallstones, gut microbiome, and obesity treatment. The program was released on August 31, 2023.
Gastroenterology and Hepatology Board Review 2023 (Course)
Gastroenterology and Hepatology Board Review is an online video CME program covering normal function, signs, symptoms, and diseases of the gastrointestinal organs — from the esophagus and stomach to the small intestine, colon, liver, pancreas, and biliary tract.
This continuing medical education program includes 40+ one-hour lectures delivered by recognized experts with extensive clinical experience. You’ll benefit from the decision-making expertise of these skilled educators as they discuss diagnostic procedures, medical therapy, surgical therapy, and procedural therapy. Presentations combine scientific evidence and clinical judgment, culminating with recommendations for the most appropriate care and improved patient outcomes.
Learning Objectives
At the conclusion of this activity, the participant will be able to:
- Describe the clinical, endoscopic, and histopathologic features of eosinophilic esophagitis
- Summarize resuscitation, initial management, transfusion recommendations, and timing of endoscopy for peptic ulcer bleeding
- Explain the differential diagnosis, evaluation, and management of diarrhea.
- Discuss inflammatory bowel disease diagnostic tools and work-up for appropriate patients
- Identify the risk factors that warrant screening for hepatitis C
- Recognize clinical trends in drug-induced liver injury
- List the possible pathogenic mechanisms of pancreatitis and how that informs drug targets and treatments
- Differentiate between acute calculous cholecystitis and acute acalculous cholecystitis
- List the core principles of obesity treatment
- Name the gastrointestinal manifestations of COVID-19 infection
Intended Audience
This educational activity was designed for gastroenterologists, hepatologists, internists, fellows in gastroenterology, and internal medicine residents interested in gastroenterology and hepatology.
TOPICS / SPEAKERS
Esophagus
Gastroesophageal Reflux Disease (GERD) and Barrett’s Esophagus – Stuart Jon Spechler, MD
Esophageal Motility and Structural Disorders – Dustin A. Carlson, MD
Update in Eosinophilic Esophagitis and Eosinophilic Gastrointestinal Diseases – Evan S. Dellon, MD, MPH
Esophageal Cancer – Anil K. Rustgi, MD
Stomach and Small Intestine
Pathophysiology of Peptic Ulcer Disease – Helen M. Shields, MD
Peptic Ulcer Hemorrhage – Diagnosis and Management – Dennis M. Jensen, MD
Motility Disorders – Gastroparesis, Functional Dyspepsia, Ileus – Braden Kuo, MD, MSc
Malabsorption and Nutrition – Henry J. Binder, MD
Viral/Bacterial Gastroenteritis – Jason B. Harris, MD, MPH
Constipation and Diarrhea – Lawrence R. Schiller, MD
Celiac Disease and Gluten Sensitivity – Peter H. R. Green, MD
Colon
Diagnosis and Management of Clostridioides difficile Infections – Jessica R. Allegretti, MD, MPH
Inflammatory Bowel Disease – Anita Afzali, MD, MPH, MHCM
Irritable Bowel Syndrome – Walter W. Chan, MD, MPH, FACG, AGAF
Ischemic Bowel Disorders – A Case Based Approach – Paul Feuerstadt, MD
Colorectal Cancer Screening Strategies – Shilpa Grover, MD, MPH
An Update on Colorectal and Anal Cancers – Robert J. Mayer, MD
Hereditary Gastrointestinal Polyposis/Cancer Syndromes – John M. Carethers, MD, MACP
Liver – Hepatitis
Viral Hepatitis Overview – Raymond T. Chung, MD
Hepatitis B – Norah Terrault, MD, MPH
Hepatitis C – Ira M. Jacobson, MD
HIV – Viral Hepatitis Co-Infection – Kenneth E. Sherman, MD, PhD
Liver – General
Drug-Induced Liver Injury – Idiosyncratic (iDILI) and Acetaminophen – William M. Lee, MD, FACP, FAASLD, AGAF
Nonalcoholic Fatty Liver Disease – Stephen A. Harrison, MD
Alcohol-Associated Hepatitis – Jay Luther, MD
Autoimmune Liver Disorders – John M. Vierling, MD, FACP, FAASLD, AGAF
Genetic Liver Disorders – Kris V. Kowdley, MD, FACP
Hepatic Decompensation – Andrea Ewing Reid, MD, MPH
Hepatocellular Carcinoma – Augusto Villanueva, MD
Liver Transplantation – Thomas D. Schiano, MD
Liver Fibrosis – Don C. Rockey, MD
Pancreas
Acute Pancreatitis – Yasmin Genevieve Hernandez-Barco, MD
Recurrent-Chronic Pancreatitis – Evaluation and New Therapies – Steven D. Freedman, MD, PhD
Update in Pancreatic Cancer – William R. Brugge, MD
Biliary Tract
Gallstones, Gallbladder, and Biliary Tract Disease – Muthoka L. Mutinga, MD
Cholangiocarcinoma – Sumera I. Ilyas, MD
Special Topics
Gut Microbiome – Aonghus Lavelle, MD, PhD
Approach to Gastrointestinal Hemorrhage – John R. Saltzman, MD
A New Era in Obesity Treatment – Lee M. Kaplan, MD, PhD
COVID-19 – Gastrointestinal Manifestations – Thomas R. McCarty, MD
Gastrointestinal and Hepatic Toxicities of Checkpoint Blockade – Michael Dougan, MD
Acute Gastrointestinal Toxicity of Novel Anti-Cancer Therapies – Shilpa Grover, MD, MPH
Date of Original Release: August 31, 2023
Related Products
